The Role of Erection Hardness in Determining Erectile Dysfunction (ED) Treatment Outcome

European Urology, Supplements

Volumn 5, Issue 13, 2006, Pages 767-772

  Dean, John ^a   de Boer, Bert Jan ^b   Graziottin, Alessandra ^c,d   Hatzichristou, Dimitrios ^e   Heaton, Jeremy ^f   Tailor, Ann ^g  

^a Prostate Centre   (United Kingdom)

^b Julius Center for Health Sciences and Primary Care   (Netherlands)

^c Center of Gynecology and Medical Sexology   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f QUEEN S UNIVERSITY   (Canada)

^g European Sexual Dysfunction Alliance ^*  (United Kingdom)

Author keywords

Erectile dysfunction; Erection hardness; Intimacy; PDE5 inhibitor; Self esteem; Sexual satisfaction

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; VARDENAFIL;

CLINICAL TRIAL; EMOTION; ERECTILE DYSFUNCTION; HARDNESS; HUMAN; OUTCOME ASSESSMENT; PENIS ERECTION; PRIORITY JOURNAL; REVIEW; SELF CONCEPT; SELF ESTEEM; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SEXUALITY; TREATMENT OUTCOME; WELLBEING;

EID: 33746975885     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2006.06.004     Document Type: Review

References (24)

1. Lue T. Erectile dysfunction. N Engl J Med 342 (2000) 1802-1813
2. Wespes E., Amar E., Hatzichristou D., et al. EAU guidelines on erectile dysfunction: an update. Eur Urol 49 (2006) 806-815
3. Rosen R., Shabsigh R., Berber M., et al. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: The Depression-Related Improvement With Vardenafil For Erectile Response Study. Am J Psychiatry 163 (2006) 79-87
4. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., and Misura A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
5. Rosen R.C., Cappelleri J.C., Smith M.D., Lipsky J., and Beña B.M. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11 (1999) 319-326
6. Gruenwald I., Chen J., Smueli Y., Ravio G., Shenfield O., and Vardi Y. What do patients expect from ED treatment?. J Sex Med 2 (2005) 19 (abstract no. PS-4-8)
7. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., and McKinlay J.B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151 (1994) 54-61
8. Nicolosi A., Laumann E.O., Glasser D.B., Moreira E.D., Paik A., Gingell C., for the Global Study of Sexual Attitudes, and Behaviours Investigators' Group. Sexual behaviour and sexual dysfunctions after age 40: the Global Study of Sexual Attitudes and Behaviours. Urology 64 (2004) 991-997
9. Rosen R.C., Fisher W.A., Eardley I., Niederberger C., Nadel A., and Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study, 1: prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 20 (2004) 603-617
10. Papaharitou S., Athanasiadis L., Nakopoulou E., et al. Erectile dysfunction and premature ejaculation are the most frequently self-reported sexual concerns: profiles of 9,536 men calling a helpline. Eur Urol 49 (2006) 557-563
11. Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
12. Tomlinson J.M., and Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil. BMJ 328 (2004) 1037-1041
13. Tudiver F., and Talbot Y. Why don't men seek help? Family physicians' perspectives on help-seeking behaviour in men. J Fam Pract 48 (1999) 47-52
14. Swierzewski M., Fusia T., Harrington M., and Haynie L. Viagra (sildenafil citrate) improves the desire for basic intimacy with increased sexual satisfaction in long-term married relationships. J Sex Med 2 Suppl 1 (2005) 25 (abstract no. PS-6-7)
15. Cookson M.S., and Nadig P.W. Long-term results with vacuum constriction device. J Urol 149 (1993) 290-294
16. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A., and for the Sildenafil Study Group. Oral sildenafil for the treatment of erectile dysfunction. N Engl J Med 338 (1998) 1397-1404
17. Brock G.B., McMahon C.G., Chen K.K., et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168 (2002) 1332-1336
18. Donatucci C., Taylor T., Thibonnier M., Bangerter K., Gittelman M., Casey R., and for the Vardenafil Study Group. Vardenafil improves patient satisfaction with erection hardness, orgasmic function and overall sexual experience, while improving quality of life in men with erectile function. J Sex Med 1 (2004) 185-192
19. Sussman D.O. Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors. JAOA 104 (2004) S11-S15
20. Montorsi F., Verheyden B., Meuleman E., et al. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol 45 (2004) 339-345
21. Padma-Nathan H., Eardley I., Kloner R.A., Laties A.M., and Montorsi F. A 4-year update on the safety of sildenafil citrate (Viagra). Urology 60 (2002) 67-90
22. Stief C., Porst H., Saenz de Tejada I., Ulbrich E., Beneke M., and for the Vardenafil Study Group. Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. Int J Clin Pract 58 (2004) 239-249
23. Levinson I.P. Improved erectile quality correlates with intercourse success in men treated with Viagra (sildenafil citrate) for erectile dysfunction. J Sex Med 2 (2005) 59 (abstract no. P-074)
24. Levinson I.P. Erectile function is associated with sexual relationship satisfaction: a pooled analysis of 26 randomized, double-blind, placebo-controlled trials. J Sex Med 2 (2005) 59 (abstract no. P-073)